Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2021)

Historic Cash from Investing Activities for ENDRA Life Sciences (NDRA) over the last 5 years, with Q1 2021 value amounting to -$45000.0.

  • ENDRA Life Sciences' Cash from Investing Activities fell 10134.23% to -$45000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$45000.0, marking a year-over-year increase of 4026.52%. This contributed to the annual value of -$12796.0 for FY2024, which is 4823.83% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Cash from Investing Activities of -$45000.0 as of Q1 2021, which was down 10134.23% from -$64850.0 recorded in Q4 2020.
  • In the past 5 years, ENDRA Life Sciences' Cash from Investing Activities ranged from a high of $11867.0 in Q3 2020 and a low of -$100000.0 during Q3 2018
  • For the 5-year period, ENDRA Life Sciences' Cash from Investing Activities averaged around -$30198.9, with its median value being -$22350.0 (2020).
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Cash from Investing Activities was 6906.95% (2020), while the steepest drop was 32660.81% (2020).
  • Over the past 5 years, ENDRA Life Sciences' Cash from Investing Activities (Quarter) stood at -$7862.0 in 2017, then plummeted by 1171.94% to -$100000.0 in 2018, then soared by 61.64% to -$38357.0 in 2019, then crashed by 69.07% to -$64850.0 in 2020, then skyrocketed by 30.61% to -$45000.0 in 2021.
  • Its Cash from Investing Activities stands at -$45000.0 for Q1 2021, versus -$64850.0 for Q4 2020 and $11867.0 for Q3 2020.